Students at Stanford Law School have started enrolling in the new Juelsgaard Intellectual Property and Innovation Clinic of the Mills Legal Clinic, which begins this winter quarter—bringing the number of distinct offerings in the clinical program to 11.

The core vision of the Juelsgaard Clinic is that intellectual property law and the regulatory climate must be developed with acute sensitivity to the ways in which laws and regulations can serve to promote or frustrate vital innovation. It is primarily a policy-focused clinic, and its clients will include nongovernmental organizations in such areas as 
biotechnology, information technology, pharmaceuticals, clean 
technology, and the creation and distribution of knowledge.

Students will have the opportunity to wrestle with complex issues including how to ensure a regulatory climate that is appropriately sensitive to the ways in which law—whether through litigation, legislation, or regulation—can support the inventiveness, creativity, and entrepreneurship that provide the real engine for economic growth. Phillip Malone joined the Stanford Law faculty in July as the inaugural director of the Juelsgaard Clinic. See his “New Faculty” profile on page 32.

The Juelsgaard Clinic has been established with generous support from Stephen Juelsgaard, JD ’82, who is keenly interested in innovation and how public policy can spur it on or hold it back. Juelsgaard, who also holds a doctorate in veterinary medicine, had a lengthy career with Genentech, including serving as chief compliance officer, executive vice president, secretary, general counsel, and vice president. He began his 
career with the biotechnology giant in July 1985 as corporate counsel. Prior to joining Genentech, 
Juelsgaard was an associate with 
the law firm of Wilson Sonsini 
Goodrich & Rosati. SL